1-3 of 3
Katja - Seipel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rebound Thrombocytosis after Induction Chemotherapy Is a Strong Biomarker for Favorable Outcome in AML Patients

Thomas Pabst, MD, Bianca R Schnell, Ulrike Bacher, Barbara Jeker, Yara Banz, Urban Novak, Katja - Seipel
Journal: Blood
Blood (2019) 134 (Supplement_1): 5101.
https://doi.org/10.1182/blood-2019-127984
Published: 2019
Journal Articles

Nelfinavir and Lenalidomide/Dexamethasone in Patients with Lenalidomide-Refractory Multiple Myeloma. A Phase I/II Trial — SAKK 39/10

Felicitas - Hitz, MD, Thomas - Pabst, MD, Dagmar - Hess, MD, Marianne Kraus, Lenka Besse, Urban Novak, MD, Katja - Seipel, MD, Stephanie - Rondeau, Silvia - Stüdeli, Simona Berardi, MD, Samaras Panagiotis, MD, Ulrich Mey, MD, Christoph Driessen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1884.
https://doi.org/10.1182/blood.V130.Suppl_1.1884.1884
Published: 2017
Journal Articles

Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity

Beatrice U. Mueller, MD, Sandra Keller, MD, Katja Seipel, PhD, Behrouz Mansouri Taleghani, MD, Thomas Pabst, MD
Journal: Blood
Blood (2015) 126 (23): 5436.
https://doi.org/10.1182/blood.V126.23.5436.5436
Published: 2015